CELLECTIS S.A. Chart calendar Cellectis S.A.
f19162c860e5e2a8870611f.FvnNHemOfxvzEpDTUomdG_WXKUpIxXqp4NyJuf9WSdw.XI-GQtnPRlfFUOShJebzfq_lTgwnkRviooTf9480fLJeq6JYgLoNLbRh-w~bdccb2ec171ff5137e2f9ce4128435dc
Upcoming events on Cellectis S.A.
Past events on Cellectis S.A.
| 03/06/2024 | Bio International Convention |
| 29/05/2024 05:30 pm | Q1 2024 Earnings Call |
| 29/05/2024 02:00 am | Q1 2024 Earnings Release |
| 14/05/2024 06:30 pm | Citizens JMP Life Sciences Conference - Fireside Chat |
| 09/05/2024 09:30 pm | American Society of Gene & Cell Therapy Meeting - Abstract Number : 1235 |
| 05/05/2024 09:30 pm | American Society of Gene & Cell Therapy Meeting - Abstract Number : 721 |
| 24/04/2024 02:45 pm | The CRISPR MEDiCiNE Conference |
| 08/04/2024 06:10 pm | GenE-HumDi Meeting |
| 19/03/2024 03:45 pm | Bioprocessing Europe Summit |
| 14/03/2024 01:05 am | Barclays Global Healthcare Conference - Fireside Chat |
| 22/12/2023 07:00 pm | Shareholders Meeting |
| 12/12/2023 07:30 am | American Society of Hematology Meeting - Poster No:P4847 |
| 10/12/2023 07:00 am | American Society of Hematology Meeting - Poster No:P2110 |
| 06/12/2023 10:30 pm | JMP Securities Hematology and Oncology Summit |
| 06/12/2023 02:30 am | Cell Therapy Analytical Development Summit |
| 28/11/2023 07:40 pm | Evercore ISI HealthCONx Conference |
| 16/11/2023 02:00 pm | Jefferies London Healthcare Conference |
| 07/11/2023 06:30 pm | Q3 2023 Earnings Call |
| 07/11/2023 03:00 am | Q3 2023 Earnings Release |
| 06/11/2023 | Bio Europe Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 20,6 19,7 4.81% | 68,5 57,6 18.77% | 60,7 55,0 10.31% | 24,5 27,2 -10.08% | 8,58 21,5 -60.11% | 34,5 |
|
EBITDA Million EUR | Released Forecast Spread | -104 -96,6 -8.03% | -62,8 -82,3 23.75% | -111 -115 2.75% | -93,9 -109 14.11% | -73,5 -38,2 -92.57% | -57,5 |
|
EBIT Million EUR | Released Forecast Spread | -111 -108 -2.56% | -70,9 -77,8 8.77% | -118 -127 7.01% | -105 -103 -1.83% | -90,8 -79,4 -14.43% | -69,4 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -103 -99,1 -4.46% | -80,9 -83,1 2.6% | -113 -123 8.06% | -108 -104 -3.73% | -101 -71,0 -41.96% | -47,6 |
|
Net income Million EUR | Released Forecast Spread | -91,7 -95,2 3.67% | -67,3 -76,7 12.23% | -103 -122 14.99% | -100 -98,0 -2.51% | -94,3 -69,5 -35.67% | -40,1 |
|
EPS EUR | Released Forecast Spread | -2,16 -3,17 31.75% | -1,59 -2,98 46.85% | -2,31 -3,16 26.91% | -2,21 -3,74 40.99% | 0,00 0,00 - | 0,00 |
| Announcement Date | 04/03/20 | 04/03/21 | 03/03/22 | 08/03/23 | 29/04/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 3,68 16,9 -78.27% | 2,70 25,4 -89.35% | 1,97 19,2 -89.76% | 16,4 20,7 -20.71% | 3,23 5,57 -41.9% | 1,83 4,26 -57.09% | 1,53 3,52 -56.57% | 1,86 14,8 -87.45% | 5,97 3,17 88.4% | 3,00 | 7,87 | 17,9 | 44,9 | 8,32 |
|
EBITDA Million EUR | Released Forecast Spread | -22,8 23,5 -196.94% | -21,5 | -24,4 | -7,79 | 19,7 | |||||||||
|
EBIT Million EUR | Released Forecast Spread | -33,8 -30,4 -11.51% | -33,3 -16,1 -107.53% | -34,0 -23,3 -45.72% | -7,92 -17,9 55.67% | -21,3 -22,1 3.5% | -21,6 -20,9 -3.57% | -19,2 -21,2 9.08% | -27,6 -14,4 -92.26% | -19,6 -23,1 15.09% | -23,2 | -20,3 | -12,2 | 6,45 | -37,1 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -33,4 -20,9 -59.93% | -19,0 -20,1 5.17% | -32,0 -23,9 -33.89% | -26,9 -14,3 -87.99% | -29,6 -18,3 -61.22% | -12,4 -19,7 36.94% | -16,2 -20,7 21.78% | -39,0 -17,9 -118.2% | 5,43 -18,5 129.34% | -20,9 | -16,8 | -5,33 | 12,6 | -30,9 |
|
Net income Million EUR | Released Forecast Spread | -30,6 -20,1 -52.41% | -18,5 -18,2 -1.63% | -29,2 -22,1 -31.7% | -25,4 -14,2 -78.29% | -27,3 -17,1 -59.48% | -9,72 -18,1 46.18% | -16,3 -19,2 15.13% | -39,0 -14,4 -171.07% | 5,19 -18,5 128.04% | -20,9 | -16,8 | -5,33 | 12,6 | -30,9 |
| Announcement Date | 12/05/22 | 04/08/22 | 03/11/22 | 08/03/23 | 04/05/23 | 03/08/23 | 06/11/23 | 29/04/24 | 28/05/24 | - | - | - | - | - |
| 15/07/2024 11:15 am | ADDLIFE AB: Q2 2024 Earnings Release |
| 22/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 24/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 25/07/2024 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 25/07/2024 10:30 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 26/07/2024 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
| 26/07/2024 10:30 am | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Cellectis S.A.
| 30/05/2024 01:31 am | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
| 23/05/2024 04:30 pm | CUREVAC N.V.: Q1 2024 Earnings Release |
| 22/05/2024 10:30 am | EVOTEC SE: Q1 2024 Earnings Release |
| 22/05/2024 02:44 am | ALVOTECH: Q1 2024 Earnings Release |
| 21/05/2024 04:30 pm | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 17/05/2024 11:30 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 16/05/2024 01:35 am | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 04:30 pm | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 15/05/2024 01:35 am | KYVERNA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
